Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
Titel:
Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
Auteur:
Takeda, Satoshi Smith, Susan Y. Tamura, Tatsuya Saito, Hitoshi Takahashi, Fumiaki Samadfam, Rana Haile, Solomon Doyle, Nancy Endo, Koichi